Bristol Myer Buy Hold or Sell Recommendation

BMYMP -- USA Stock  

USD 813.95  0.00  0.00%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bristol Myer Squi Pf is 'Hold'. Macroaxis provides Bristol Myer buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BMYMP positions. The advice algorithm takes into account all of Bristol Myer Squi available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BMYMP buy-and-hold prospective. Check also Bristol Myer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell Bristol MyerBuy Bristol Myer


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Bristol Myer Squi Pf has a risk adjusted performance of 0.003, jensen alpha of (0.030311), total risk alpha of (0.09), sortino ratio of 0.0 and treynor ratio of (0.15)
Macroaxis provides buy, hold, or sell suggestion on Bristol Myer Squi to complement and cross-verify current analyst consensus on Bristol Myer Squi Pf. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Bristol Myer is not overpriced, please confirm all Bristol Myer Squi fundamentals including its Cash per Share, and the relationship between Revenue and Cash Flow from Operations . Given that Bristol Myer Squi has Price to Book of 117.91X, we suggest you validate Bristol Myer Squi Pf market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Bristol Myer Trading Alerts and Improvement Suggestions

Bristol Myer Squi generates negative expected return over the last 30 days
Bristol Myer Squi has high historical volatility and very poor performance
On August 5, 2019 Bristol Myer paid $ 0.5 per share dividend to its current shareholders
Latest headline from Heres How Over-The-Counter Drug Market Growing with High Growth Rate Bayer HealthCare, GlaxoSmithKline , Johnson Johnson, Pfizer, Sanofi, AstraZeneca, BioGaia, Bristol Myers Squibb, Bukwang Pharmaceutica - Market Report Gazette

Bristol Myer Returns Distribution Density

Mean Return0.02Value At Risk0.00
Potential Upside0.06Standard Deviation3.44
 Return Density 

Bristol Myer Greeks

Alpha over DOW
Beta against DOW=0.19
Overall volatility
Information ratio =0.01

Bristol Myer Volatility Alert

Bristol Myer Squi Pf exhibits very low volatility with skewness of 3.78 and kurtosis of 31.92. However, we advise investors to further study Bristol Myer Squi Pf technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Bristol Myer to competition

Bristol Myer Fundamental Vs Peers

FundamentalsBristol MyerPeer Average
Return On Equity2.97% (0.31)%
Return On Asset10.68% (0.14)%
Profit Margin1.74% (1.27)%
Operating Margin26.12% (5.51)%
Shares Outstanding1.64B571.82M
Number of Shares Shorted104.71M
Price to Book117.91X9.51X
Price to Sales67.57X11.42X
Gross Profit14.71B27.38B
Net Income376M570.98M
Cash and Equivalents6.07B2.7B
Cash per Share3.72X5.01X
Total Debt7.39B5.32B
Debt to Equity59.40% 48.70%
Current Ratio1.40X2.16X
Book Value Per Share7.55X1.93K
Cash Flow from Operations5.06B971.22M
Short Ratio0.59X4.00X
Earnings Per Share0.22X3.12X
Number of Employees23.7K18.84K
Market Capitalization1330B19.03B
Last Dividend Paid0.5